Université de Liège
11
1
1
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
18.2%
2 terminated/withdrawn out of 11 trials
60.0%
-26.5% vs industry average
18%
2 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Renal and Vascular Phenotypic Characterization of Patients With Enamel Renal Syndrome Due to a Pathogenic Variant of the FAM20A Gene and Pathophysiological Study of Ectopic Calcifications
Role: collaborator
The Belgian Genome Resource to Resolve Rare Diseases
Role: collaborator
CAP48 - Autism in Children and Adolescents
Role: collaborator
Community Pharmacist Intervention to Enhance Adherence in Cardiovascular Drug Initiators
Role: collaborator
The DAWN Antivirals Trial for Ambulatory COVID-19 Patients
Role: collaborator
Blended Care for the Discontinuation of Benzodiazepine Use
Role: collaborator
Effectiveness of Removable Prosthesis Retained by 4 Implant-supported Locator-Attachments
Role: collaborator
Bronchodilators for Wheeze in Young Children Presenting to Primary Care: a Randomised, Placebo-controlled, Multicentre, Parallel Group Trial
Role: collaborator
New Markers of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Function in Sweat
Role: collaborator
Randomized Controlled Trial Assessing the Efficacy of a Communication Skills Training Program
Role: collaborator
Mental Health Related to School Dropout in Luxembourg
Role: collaborator
All 11 trials loaded